SHE:300832 - Shenzhen New Industries Biomedical Engineering Co Ltd

Shenzhen New Industries Biomed
Sector: Health Care, Industry: Health Care Equipment

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	91.22% -	70% -23.3%	67.42% -3.7%
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	38.25% -10.6%	43.58% 13.9%	42.08% -3.4%
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	71.15% -7.8%	70.26% -1.3%	72.96% 3.8%
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	42.71% -12.8%	44.9% 5.1%	45.37% 1.1%
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.55B 16.0%	3.05B 19.7%	3.93B 29.0%
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	6.14B 15.6%	7.01B 14.3%	8.22B 17.2%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	523.51M 3.9%	615.06M 17.5%	678.09M 10.2%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	5.61B 16.8%	6.4B 14.0%	7.54B 17.9%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	773.22M -20.8%	962.39M 24.5%	1.42B 47.4%
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.07B -45.6%	616.02M -42.4%	478.12M -22.4%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	616.02M -42.4%	478.12M -22.4%	1.05B 118.7%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	430.28M -40.4%	559.17M 30.0%	1.1B 96.0%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	973.7M 3.7%	1.33B 36.4%	1.65B 24.5%
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.239 -1.0%	1.689 36.3%	2.104 24.6%
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	18.7% -20.9%	22.11% 18.3%	23.72% 7.3%
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	17.02% -20.6%	20.2% 18.7%	21.71% 7.5%